Literature DB >> 8893768

Gentamicin distribution from a collagen carrier.

S Mehta1, J S Humphrey, D I Schenkman, A V Seaber, T P Vail.   

Abstract

Local delivery of antibiotics by a degradable carrier has the potential for high local antibiotic levels and avoids systemic toxicity. Intravenous access, renal function monitoring, and subsequent surgical removal may not be required when degradable local delivery modalities are used. This study examined the in vivo elution of gentamicin from processed bovine collagen (type I) in 66 adult White rabbits. Collagen impregnated with gentamicin (3 mg/kg) was implanted into the vastus lateralis, and data were collected from 15 minutes to 28 days after implantation. Local tissue biopsies were taken a minimum of 2 mm from the implantation site. The gentamicin was released into the local tissue and averaged more than 3,800 micrograms/ml during the initial 4 hours after implantation. Local levels fell to 6.90 +/- 5.22 micrograms/ml at 24 hours and subsequently were 2.70 +/- 1.75 micrograms/ml or more through day 28. Serum levels reached an average peak of 4.04 +/- 1.75 micrograms/ml at 5 hours after implantation, decreased after the initial 24 hours, and subsequently were less than 0.41 +/- 0.20 microgram/ml through day 28. Collagen impregnated with gentamicin proved to be an effective degradable carrier of gentamicin in the healthy rabbit; it provided local tissue concentrations above the minimum inhibitory concentration and serum concentrations below levels associated with systemic toxicity for 28 days after implantation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893768     DOI: 10.1002/jor.1100140511

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  8 in total

1.  Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.

Authors:  Scott P Noel; Harry S Courtney; Joel D Bumgardner; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Temperature-responsive PNDJ hydrogels provide high and sustained antimicrobial concentrations in surgical sites.

Authors:  Derek J Overstreet; Vajra S Badha; John M Heffernan; Erin P Childers; Rex C Moore; Brent L Vernon; Alex C McLaren
Journal:  Drug Deliv Transl Res       Date:  2019-08       Impact factor: 4.617

Review 3.  [Replacement of infected knee and hip endoprostheses].

Authors:  M Militz; V Bühren
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

Review 4.  Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts.

Authors:  Jesse Wp Kuiper; Robin Tjeenk Willink; Dirk Jan F Moojen; Michel Pj van den Bekerom; Sascha Colen
Journal:  World J Orthop       Date:  2014-11-18

5.  Prospective, randomized trial examining the role of gentamycin-containing collagen sponge in the reduction of postoperative morbidity in rectal cancer patients: early results and surprising outcome at 3-year follow-up.

Authors:  Marek P Nowacki; Andrzej Rutkowski; Janusz Oledzki; Maciej Chwaliński
Journal:  Int J Colorectal Dis       Date:  2004-09-15       Impact factor: 2.571

6.  Septic arthritis of the knee joint secondary to adjacent chronic osteomyelitis of the femur in an adult.

Authors:  Woong-Kyo Jeong; Jong-Hoon Park; Soon-Hyuck Lee; Jong-Woong Park; Seung-Beom Han; Dae-Hee Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-11-05       Impact factor: 4.342

7.  The management of concomitant septic arthritis of the knee and femoral osteomyelitis - A case series and literature review.

Authors:  Chee Chung Jonathan Low; Rex Premchand Anthony Xavier; Gek Meng Tan; Chung Hui James Tan; Derek Howard Park
Journal:  Trauma Case Rep       Date:  2021-02-10

8.  Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection.

Authors:  Bianca L Price; Andrew M Lovering; Frank L Bowling; Curtis B Dobson
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.